Category: Lillys
-
Viking obesity drug to rival Eli Lilly’s: report (NASDAQ:VKTX)
•
Carolina Rhoda/iStock via Getty Images Eli Lilly (NYSE:LLYPopular obesity treatment Zepbound could face direct competition from Viking TherapeuticsNASDAQ:VKTX), with the latter expected to launch its flagship weight loss product VK2735 within the next few years, according to data analytics firm GlobalData. He said this week. The prediction comes after the…